-+ 0.00%
-+ 0.00%
-+ 0.00%

Plus Therapeutics Q1 EPS $(1.19) Misses $(0.25) Estimate, Sales $1.06M Miss $1.48M Estimate

Benzinga·05/30/2025 20:19:10
Listen to the news
Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.25) by 376 percent. This is a 58.67 percent decrease over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $1.06 million which missed the analyst consensus estimate of $1.48 million by 28.61 percent. This is a 36.85 percent decrease over sales of $1.68 million the same period last year.